Doximity, Inc.

NYSE:DOCS

59.35 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 168.603136.832126.676118.057135.284113.612108.469110.966115.262102.18590.63993.65397.87679.3572.66966.68758.70945.11336.38836.35432.426
Cost of Revenue 14.18113.67613.5512.56712.1912.75913.15313.67713.52613.2113.07711.76511.0858.9517.9867.9937.8727.4567.8754.2813.78
Gross Profit 154.422123.156113.126105.49123.094100.85395.31697.289101.73688.97577.56281.88886.79170.39964.68358.69450.83737.65728.51332.07328.646
Gross Profit Ratio 0.9160.90.8930.8940.910.8880.8790.8770.8830.8710.8560.8740.8870.8870.890.880.8660.8350.7840.8820.883
Reseach & Development Expenses 22.42123.2422.57420.14819.94619.95821.93121.54120.51919.10419.02217.42416.22515.4613.24112.55811.4069.86610.0438.8918.605
General & Administrative Expenses 13.58510.1039.2559.9739.6418.9669.2479.7599.5138.7498.72410.6449.0798.8277.1965.7034.4783.2093.1021.7681.954
Selling & Marketing Expenses 38.49134.36735.24433.51734.95630.20134.45533.14833.2229.02128.13425.89925.69821.16119.37117.58617.01714.14513.28510.35210.669
SG&A 52.07644.4744.29743.4944.59739.16743.70242.90742.73337.7736.85836.54334.77729.98826.56723.28921.49517.35416.38712.1212.623
Other Expenses 02.304-0.0520.073-0.0555.9034.8393.8752.4610.9080.804-0.0160.02-0.02-0.031-0.2634.601-0.093-0.2900
Operating Expenses 74.49770.01466.87163.63864.54359.12565.63364.44863.25256.87455.8853.96751.00245.44839.80835.84732.90127.2226.4322.21721.265
Operating Income 79.92553.14246.25541.85258.55133.79229.68332.84138.48432.10121.68227.92135.78924.95124.87522.84717.93610.4372.08311.0627.418
Operating Income Ratio 0.4740.3880.3650.3550.4330.2970.2740.2960.3340.3140.2390.2980.3660.3140.3420.3430.3060.2310.0570.3040.229
Total Other Income Expenses Net 9.9159.0297.1166.1014.4815.9034.8393.8752.4610.9080.804-0.0160.020.420.0450.0384.601-0.02-0.153-0.8860.325
Income Before Tax 89.8462.17153.16947.95363.03239.69534.52236.71640.94533.00922.48627.90535.80925.37124.9222.88522.53710.4171.9310.1767.743
Income Before Tax Ratio 0.5330.4540.420.4060.4660.3490.3180.3310.3550.3230.2480.2980.3660.320.3430.3430.3840.2310.0530.280.239
Income Tax Expense 14.64418.01711.7927.33515.0769.0936.1166.0487.4776.710.103-8.821-19.838-10.717-1.4021.4025.3060.380.4712.7071.84
Net Income 75.19644.15441.37740.61847.95630.60228.40630.66833.46826.29922.38336.72655.64736.08826.32221.48317.23110.0371.4593.5145.903
Net Income Ratio 0.4460.3230.3270.3440.3540.2690.2620.2760.290.2570.2470.3920.5690.4550.3620.3220.2930.2220.040.0970.182
EPS 0.40.240.220.220.260.160.150.160.170.120.120.170.30.190.120.250.0360.0110.010.0450.072
EPS Diluted 0.370.220.210.20.240.150.130.140.160.120.10.170.260.170.090.190.0320.010.010.0430.072
EBITDA 79.92558.05948.81744.461.0644.33229.68339.96138.48432.10121.68229.57535.78924.95124.87524.29718.45111.3652.85111.3647.617
EBITDA Ratio 0.4740.4240.3850.3760.4510.390.2740.360.3340.3140.2390.3160.3660.3140.3420.3640.3140.2520.0780.3130.235